
AgeCurve is a company developing an AI-driven multiomics platform focused on aging drug discovery and precision drug optimization at the individual level. They combine somatic genotype with cellular phenotype at the single-cell level, leveraging machine learning and AI to build advanced aging diagnostics and therapeutics tools. Their approach is supported by published scientific research, positioning them in the aging biotech and precision medicine market with a focus on personalized aging interventions.

AgeCurve is a company developing an AI-driven multiomics platform focused on aging drug discovery and precision drug optimization at the individual level. They combine somatic genotype with cellular phenotype at the single-cell level, leveraging machine learning and AI to build advanced aging diagnostics and therapeutics tools. Their approach is supported by published scientific research, positioning them in the aging biotech and precision medicine market with a focus on personalized aging interventions.